MENU
+Compare
SIBN
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$14.49
Change
-$0.01 (-0.07%)
Capitalization
625.11M

SIBN SI-BONE Forecast, Technical & Fundamental Analysis

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally... Show more

SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SIBN with price predictions
Oct 03, 2025

SIBN's RSI Indicator ascending out of oversold territory

The RSI Indicator for SIBN moved out of oversold territory on September 29, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where SIBN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on October 03, 2025. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

SIBN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SIBN as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for SIBN moved below the 200-day moving average on September 25, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SIBN entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.670) is normal, around the industry mean (61.354). P/E Ratio (0.000) is within average values for comparable stocks, (37.462). SIBN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.691). SIBN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (3.299) is also within normal values, averaging (81.049).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SIBN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SIBN is expected to report earnings to rise 18.79% to -16 cents per share on November 10

SI-BONE SIBN Stock Earnings Reports
Q3'25
Est.
$-0.17
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.08
The last earnings report on August 04 showed earnings per share of -14 cents, beating the estimate of -18 cents. With 446.12K shares outstanding, the current market capitalization sits at 625.11M.
A.I. Advisor
published General Information

General Information

a sacroiliac joint medical device company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
471 El Camino Real
Phone
+1 408 207-0700
Employees
344
Web
https://www.si-bone.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAPTX11.830.05
+0.42%
Canterbury Portfolio Thermostat I
TRVHX19.170.05
+0.26%
Nuveen Mid Cap Value I
PDIAX22.290.05
+0.22%
Virtus KAR Equity Income A
SVBIX31.710.03
+0.09%
JHancock Balanced I
LCORX24.03-0.05
-0.21%
Leuthold Core Investment Retail

SIBN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with TMCI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+1.33%
TMCI - SIBN
41%
Loosely correlated
+1.60%
ATRC - SIBN
40%
Loosely correlated
+1.52%
DCTH - SIBN
40%
Loosely correlated
+4.23%
UFPT - SIBN
39%
Loosely correlated
-0.12%
AVNS - SIBN
39%
Loosely correlated
+4.06%
More

Groups containing SIBN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+1.33%
Medical/Nursing Services
industry (224 stocks)
41%
Loosely correlated
+0.26%
Health Services
industry (434 stocks)
32%
Poorly correlated
+0.42%